G01N 2800/382
Cystic fibrosis
G01N2800/382 (Cystic fibrosis) appears on 67 US grants and 119 published applications in this corpus.
Search patents in G01N- Granted patents
- 67
- Published applications
- 119
- Assignees
- 67
- Inventors
- 287
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 3 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 1 |
| 2002 | 0 | 2 |
| 2003 | 2 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 3 |
| 2006 | 1 | 4 |
| 2007 | 2 | 2 |
| 2008 | 0 | 4 |
| 2009 | 0 | 3 |
| 2010 | 4 | 4 |
| 2011 | 2 | 7 |
| 2012 | 1 | 10 |
| 2013 | 3 | 6 |
| 2014 | 5 | 8 |
| 2015 | 2 | 8 |
| 2016 | 2 | 6 |
| 2017 | 2 | 7 |
| 2018 | 5 | 4 |
| 2019 | 3 | 7 |
| 2020 | 5 | 8 |
| 2021 | 3 | 3 |
| 2022 | 3 | 5 |
| 2023 | 2 | 5 |
| 2024 | 4 | 6 |
| 2025 | 6 | 3 |
| 2026 | 2 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for measuring COPD biomarkers25 Aug 2026US 12,716,898 B2St. John's University
- Compositions and methods for using engineered deubiquitinases for probing ubiquitin-dependent cellular processes24 Feb 2026US 12,559,739 B2The Trustees of Columbia University in the City of New York
- Thin, soft, skin-mounted microfluidic networks for detection and analysis of targets of interest in sweat23 Sep 2025US 12,419,570 B2Northwestern University
- Compositions and methods for treatment of lung function9 Sep 2025US 12,411,144 B2Children's Hospital Medical Center
- Compositions and methods for using engineered deubiquitinases for probing ubiquitin-dependent cellular processes8 Jul 2025US 12,351,844 B2The Trustees of Columbia University in the City of New York
- Compositions and methods for using engineered deubiquitinases for probing ubiquitin-dependent cellular processes13 Aug 2026US 2026/0234594 A1The Trustees of Columbia University in the City of New York
- Method and device for predicting significant gastric aspiration and lung transplant outcome30 Jul 2026US 2026/0219272 A1University Health Network
- Compositions and methods for using engineered deubiquitinases for probing ubiquitin-dependent cellular processes1 Jan 2026US 2026/0002144 A1The Trustees of Columbia University in the City of New York
- Compositions and methods for using engineered deubiquitinases for probing ubiquitin-dependent cellular processes18 Sep 2025US 2025/0290059 A1The Trustees of Columbia University in the City of New York
- Compositions and methods for using engineered deubiquitinases for probing ubiquitin-dependent cellular processes28 Aug 2025US 2025/0270533 A1The Trustees of Columbia University in the City of New York
Most cited
By later US patents
- Modulators of cystic fibrosis transmembrane conductance regulator80US 8,513,282 B2Vertex Pharmaceuticals Incorporated · 2013
- Modulators of cystic fibrosis transmembrane conductance regulator74US 8,598,205 B2Vertex Pharmaceuticals Incorporated · 2013
- Modulators of cystic fibrosis transmembrane conductance regulator73US 8,614,325 B2Vertex Pharmaceuticals Incorporated · 2013
- Modulators of cystic fibrosis transmembrane conductance regulator73US 8,796,308 B2Vertex Pharamaceuticals Incorporated · 2014
- Modulators of cystic fibrosis transmembrane conductance regulator71US 8,785,640 B2Vertex Pharmaceuticals Incorporated · 2014